Ion Beam Applications SA
Belgium · BE0003766806 · reports in EUR · Europe
The answers
From the annual report for the year to Dec 31, 2025. Each line says what it is based on.
- Is it growing?Good
- Revenue +24% in the year to Dec 31, 2025, on the year before.
- Is it a good business?Fair
- It earned 10% on its shareholders' equity in the year to Dec 31, 2025.
- Is it safe?To watch
- Equity is 18% of its assets, and operations used cash in the year.
- Is the price fair?n/a
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Dec 31, 2025, consolidated, in EUR.
revenue
operating margin
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|
| Revenue | €361M | €429M | €498M | €620M |
| Operating profit | €5M | €5M | €20M | €28M |
| Earnings per share | €0.21 | −€3128.00 | n/a | €0.43 |
| Dividend per share | n/a | €0.21 | n/a | €0.24 |
| Cash from operations | €22M | −€20M | −€11M | −€26M |
| Capital spending | €3M | €5M | €4M | €9M |
| Cash | €158M | €109M | €72M | €65M |
| Total assets | €624M | €598M | €616M | €691M |
| Equity | €116M | €106M | €111M | €127M |
What they do
In the company's own words, from the annual report.
1.1. ENTITÉ PRÉSENTANT LES ÉTATS FINANCIERS CONSOLIDÉS Ion Beam Applications SA (la « Société » ou la « Société Mère »), fondée en 1986, et ses filiales (ensemble, le « Groupe » ou « IBA ») conçoit, produit et commercialise des solutions innovantes pour le diagnostic et le traitement du cancer et d’autres maladies graves, ainsi que pour des applications industrielles telles que la stérilisation de dispositifs médicaux.
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.